Akin Gump Counsels CITIC in Buyout Bid for Chinese Biotech Firm

Akin Gump is advising a unit of China’s CITIC Private Equity Funds Management Co. in its buyout bid, as part of a consortium, for Chinese biotech firm 3SBio Inc.  The deal would value the company at $331 million and take it private.

3SBio is based in Shenyang, China, and focuses on R&D, manufacturing and marketing biopharmaceutical products, primarily in China, related to nephrology, oncology and infection diseases, among others.